(Q51600138)

English

Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen.

scientific article published in October 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15479440

Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen. (English)

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15479440

chronic hepatitis B

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

Nikolai Petrovsky

11

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15479440

author name string

Aguilar JC

1

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15479440

Lobaina Y

2

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15479440

Muzio V

3

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15479440

García D

4

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15479440

Pentón E

5

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15479440

Iglesias E

6

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15479440

Pichardo D

7

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15479440

Urquiza D

8

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15479440

Rodríguez D

9

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15479440

Silva D

10

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15479440

Guillén G

12

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15479440

publication date

1 October 2004

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15479440

Immunology & Cell Biology

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15479440

82

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15479440

5

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15479440

539-546

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15479440

Immunogenicity of peptide fusions to hepatitis B virus core antigen

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Recombinant core particles of hepatitis B virus exposing foreign antigenic determinants on their surface

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Overview of the pathogenesis, prophylaxis and therapeusis of viral hepatitis B, with focus on reduction to practical applications

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Structural characterization of plant-derived hepatitis B surface antigen employed in oral immunization studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

HCV core protein modulates the immune response against the HBV surface antigen in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Recombinant hepatitis B core antigen carrying preS1 epitopes induce immune response against chronic HBV infection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

The Lack of Effect of Therapeutic Vaccination With a Pre-S2/S HBV Vaccine in the Immune Tolerant Phase of Chronic HBV Infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Towards immunotherapy for chronic hepatitis B virus infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

The treatment of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Hepatitis B virus immunopathogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Selective functional deficit in dendritic cell--T cell interaction is a crucial mechanism in chronic hepatitis B virus infection.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Hepatitis B virus-induced defect of monocyte-derived dendritic cells leads to impaired T helper type 1 response in vitro: mechanisms for viral immune escape

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Antigen sampling across epithelial barriers and induction of mucosal immune responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Priming Th1 immunity to viral core particles is facilitated by trace amounts of RNA bound to its arginine-rich domain

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Similar as well as distinct MHC class I-binding peptides are generated by exogenous and endogenous processing of hepatitis B virus surface antigen

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Hepatitis B virus core antigen: enhancement of its production in Escherichia coli, and interaction of the core particles with the viral surface antigen.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Controlled release of Bordetella bronchiseptica dermonecrotoxin (BBD) vaccine from BBD-loaded chitosan microspheres in vitro

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Physicochemical Characterization of Influenza Viral Vaccine Loaded Surfactant Vesicles

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Role of B cells in antigen presentation of the hepatitis B core

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Dynamic study of HBsAg and HBeAg in saliva samples from patients with hepatitis B infection: diagnostic and epidemiological significance

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Oral tolerance: immune mechanisms and treatment of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent.

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

New strategies for using mucosal vaccination to achieve more effective immunization

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01278.X

21 January 2018

Identifiers

10.1111/J.0818-9641.2004.01278.X

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15479440

1 reference

Europe PubMed Central

7 April 2018

http://europepmc.org/abstract/MED/15479440

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51600138&oldid=1590421622"